The pharmacologic treatment of vasospasm after subarachnoid hemorrhage: a case study.
The patient with a diagnosis of SAH and subsequent vasospasm presents many nursing challenges and requires complex pharmacologic management. By paying careful attention to the therapeutic and potential side effects of the medications prescribed, the nurse can be instrumental in the patient's recovery.
LeStrange
Danielle G
DG
Emergency Department, Westchester Medical Center, Valhalla, NY, USA. danilestrange@optonline.net
D000328:Adult; D001794:Blood Pressure / Q000187:drug effects; D001921:Brain / Q000000981:diagnostic imaging; D002316:Cardiotonic Agents / Q000008:administration & dosage / Q000494:pharmacology; D004280:Dobutamine / Q000008:administration & dosage / Q000494:pharmacology; D005260:Female; D005440:Fluid Therapy / Q000379:methods; D006438:Hemodilution / Q000379:methods; D006801:Humans; D002532:Intracranial Aneurysm / Q000150:complications; D009553:Nimodipine / Q000627:therapeutic use*; D013345:Subarachnoid Hemorrhage / Q000209:etiology / Q000601:surgery*; D014057:Tomography, X-Ray Computed; D014665:Vasodilator Agents / Q000627:therapeutic use*; D020301:Vasospasm, Intracranial / Q000175:diagnosis / Q000188:drug therapy / Q000628:therapy*
D002316:Cardiotonic Agents; D014665:Vasodilator Agents; D004280:Dobutamine; D009553:Nimodipine